Glyconjugate Vaccines
US-2024382585-A1 · Nov 21, 2024 · US
US9102970B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9102970-B2 |
| Application number | US-201414276838-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 13, 2014 |
| Priority date | Sep 21, 2010 |
| Publication date | Aug 11, 2015 |
| Grant date | Aug 11, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The subject invention provides an improved process for the production of human growth hormone.
Opening claim text (preview).
The invention claimed is: 1. A process for the production of human growth hormone (hGH) comprising: i. fermenting human growth hormone producing E. coli cells; ii. recovering inclusion bodies from the E. coli cells and dissolving the recovered inclusion bodies at an alkaline pH to provide dissolved hGH; iii. optionally lyophilizing dissolved hGH; and wherein the fermentation is carried out in a culture medium comprising manganese, zinc, cobalt, molybdenum, calciu…
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.